Thomas H. Adams: interview

• Recorded August 4, 1997

• UC San Diego

• Adams, Thomas H.

• Jones, Mark, 1958-

Dr. Thomas H. Adams holds a Ph.D. in Biochemistry from the University of California, Riverside. Dr. Adams founded Gen-Probe, Inc. in 1983 and served as its Chief Executive Officer and Chairman until its acquisition by Chugai Biopharmaceuticals, Inc. in 1989. Dr. Adams subsequently founded Genta, Inc., a publicly held biotechnology company in the field of antisense technology, and served as its Chief Executive Officer until 1997. Before founding Gen-Probe, Dr. Adams held management positions at Hybritech, Technicon Instruments, and the Hyland Division of Baxter Travenol.

At the time of this interview, Dr. Adams served as the Chief Executive Officer of Genta, Inc.

• San Diego (Calif.)

• Baxter International Inc.
• Biosite Incorporated
• Gen-Probe (Firm)
• Gensia Sicor Pharmaceuticals Inc.
• Hybritech, Inc.
• IDEC Pharmeceuticals
• Nanogen Biopharmaceutical
• NE.I. du Pont de Nemours & Company
• Technicon Instruments Corporation

• Biopharmaceutical technology
• Life sciences
• Pharmaceutical industry--Research

• text

• English

Related

• Thomas H. Adams SDTA Profile

• UC Regents

Adams, Thomas H.. Interview conducted by Mark Jones, August 4, 1997. The San Diego Technology Archive (SDTA), UC San Diego Library, La Jolla, CA.

Under copyright (US)

Use: This work is available from the UC San Diego Library. This digital copy of the work is intended to support research, teaching, and private study.

Constraint(s) on Use: This work is protected by the U.S. Copyright Law (Title 17, U.S.C.). Use of this work beyond that allowed by "fair use" requires written permission of the UC Regents. Responsibility for obtaining permissions and any use and distribution of this work rests exclusively with the user and not the UC San Diego Library. Inquiries can be made to the UC San Diego Library program having custody of the work.

Special Collections & Archives, UC San Diego, La Jolla, 92093-0175 (https://lib.ucsd.edu/sca)

2020-10-27